International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma
about
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategiesA review for solitary plasmacytoma of bone and extramedullary plasmacytomaMusculoskeletal complications of haematological disease¹⁸F-fluoro-deoxyglucose positron emission tomography in assessment of myeloma-related bone disease: a systematic reviewSellar solitary plasmacytoma progressing to multiple myeloma: a case report and literature reviewImaging of multiple myeloma: Current conceptsMultiple myeloma: 2014 Update on diagnosis, risk-stratification, and managementDiagnosis and treatment of bone disease in multiple myeloma: spotlight on spinal involvementEvolving Paradigms in the Management of Multiple Myeloma: Novel Agents and Targeted TherapiesWaldenstrom's macroglobulinemia: Recent advances in biology and therapy(18)F-FDG-PET/CT imaging in an IL-6- and MYC-driven mouse model of human multiple myeloma affords objective evaluation of plasma cell tumor progression and therapeutic response to the proteasome inhibitor ixazomib.Magnetic resonance evaluation of multiple myeloma at 3.0 Tesla: how do bone marrow plasma cell percentage and selection of protocols affect lesion conspicuity?Smoldering (asymptomatic) multiple myeloma: current diagnostic criteria, new predictors of outcome, and follow-up recommendations.Neuro-Myelomatosis of the Brachial Plexus - An Unusual Site of Disease Visualized by FDG-PET/CT: A Case ReportThe clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network.Combining FDG-PET/CT with laboratory data yields superior results for prediction of relapse in multiple myeloma.Case report on renal failure reversal in lambda chain multiple myeloma with bortezomib and dexamethasone.Diffusion-weighted imaging for non-invasive and quantitative monitoring of bone marrow infiltration in patients with monoclonal plasma cell disease: a comparative study with histology.Spotlight on lenalidomide in relapsed or refractory multiple myeloma.The role of magnetic resonance imaging in the evaluation of bone tumours and tumour-like lesions.Solitary bone plasmacytomas need to flow18 FDG-PET/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantation.Molecular imaging in myeloma precursor disease.Targeting paraprotein biosynthesis for non-invasive characterization of myeloma biology.Dkk-1 and IL-7 in plasma of patients with multiple myeloma prevent differentiation of mesenchymal stem cells into osteoblastsCYP2C8 gene polymorphism and bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma.Comparison of (11)C-4'-thiothymidine, (11)C-methionine, and (18)F-FDG PET/CT for the detection of active lesions of multiple myeloma.Bone disease in multiple myeloma and precursor disease: novel diagnostic approaches and implications on clinical management.Multiple myeloma presenting as acute renal failureTrends and outcomes of modern staging of solitary plasmacytoma of boneAssessing myeloma bone disease with whole-body diffusion-weighted imaging: comparison with x-ray skeletal survey by region and relationship with laboratory estimates of disease burden.A magnetic resonance imaging-based prognostic scoring system to predict outcome in transplant-eligible patients with multiple myeloma.Diagnostic and Prognostic Implications of Spine Magnetic Resonance Imaging at Diagnosis in Patients with Multiple Myeloma.The KISS1 Receptor as an In Vivo Microenvironment Imaging Biomarker of Multiple Myeloma Bone DiseaseEuropean Myeloma Network guidelines for the management of multiple myeloma-related complications.Prognostic significance of focal lesions and diffuse infiltration on MRI for multiple myeloma: a meta-analysis.Extramedullary involvement in multiple myeloma.A retrospective study of skeletal and disease-free survival benefits of zoledronic acid therapy in patients with multiple myeloma treated with novel agents.Current and future imaging modalities for multiple myeloma and its precursor states.Whole body diffusion weighted MRI--a new view of myeloma.
P2860
Q24607241-DA2C87AA-541E-4F82-BBA1-8B2BD071AD64Q24619913-AE9222AC-4B96-40E0-9180-DF5BDEAB64AFQ26786755-60150B30-8235-4EF7-8880-A8790B12CC5BQ26823362-07D80990-56C8-4499-B57E-0279963F9177Q26829219-9687B22C-FC70-47FD-8CA1-9F3B09BEB2C1Q26864616-B82E47B2-39FB-44F4-B590-57398D4388B2Q26998884-1DEC371B-D6D7-44EC-B408-C80DFC57DFD7Q27011865-2217BE40-18D2-4006-82EC-2FE118C908D8Q27026478-27E6845D-DA3C-496D-B0BF-177E689B3864Q28269017-980212EB-67D8-4353-8925-6179C9B57F0DQ30561836-2AEFE26B-F4B2-4CF7-A1B0-35D787E275F5Q30747155-CB39E9AA-D3DB-4BA1-9D23-DC0C94D6201EQ33628815-B7B83948-B5AB-428B-B5AD-C6ABDEA00BA6Q33647666-96BACA2E-384E-4C79-B0DC-885604438D58Q33695919-24538866-5496-46B9-BBF9-F4A7AB45A3C4Q33783925-EA038FE5-7A3E-4D9A-8021-38D28027DA8AQ33874209-0D9099EA-2A65-461B-8EC0-55DF9A4C8668Q33881446-33D907F9-1084-4D40-8845-898B1ABAF661Q34028642-0A9E2E3F-81F6-4575-8A34-7BDD4DE30E70Q34077323-8D14593D-4B03-4300-B87D-A9B9237CE145Q34077757-48C07955-4D6D-4D03-A269-76AC10095DDDQ34365686-A94587A3-6730-4ECA-8D91-2A1C7DCC4A2FQ34505016-E53F1C40-6670-40BC-AE20-DF26C419DC96Q35078496-B6E97916-4404-4E49-A49D-8A3737D33BCDQ35144762-3419E141-DFC8-4224-965E-33A3AE3EE916Q35266066-548EC92E-2CBD-4EFC-B503-C704802ADB9AQ35266123-0BCE2B5E-7A68-4FB5-9816-DB635E67C74BQ35422468-45342669-5720-4B53-A928-6D4436575601Q35488351-20483D55-0742-404B-BC54-111DA85B6A61Q35632671-BCE4285B-B172-462B-B182-AFA8C16159B5Q35645547-EA371964-93A2-4538-A541-37A6C0CFFDA2Q35669888-33059795-9ACA-4EA1-8768-92130AA8FD8EQ35862304-37B1C5C9-9D7C-48E0-833B-51D2F7E14C0CQ36011988-4BD67B84-F036-44B7-A6BB-1DF94235D8E6Q36115636-091C76F4-6A7A-4C63-98A7-81244ABCF90CQ36123252-A237E673-61CB-4A37-AB49-E629463BCA5AQ36366548-10BF7B6D-7A1A-4910-9534-B4F07166B828Q36449801-C56D5238-7943-4997-83CF-A30A614C2B11Q36457735-A5B72DE2-22B1-4041-A902-D229CCC8C0C5Q36532924-550921DC-BCDB-4B5C-8704-AC928E348A65
P2860
International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
International myeloma working ...... monitoring of multiple Myeloma
@ast
International myeloma working ...... monitoring of multiple Myeloma
@en
International myeloma working ...... monitoring of multiple Myeloma
@nl
type
label
International myeloma working ...... monitoring of multiple Myeloma
@ast
International myeloma working ...... monitoring of multiple Myeloma
@en
International myeloma working ...... monitoring of multiple Myeloma
@nl
prefLabel
International myeloma working ...... monitoring of multiple Myeloma
@ast
International myeloma working ...... monitoring of multiple Myeloma
@en
International myeloma working ...... monitoring of multiple Myeloma
@nl
P2093
P2860
P3181
P356
P1433
P1476
International myeloma working ...... monitoring of multiple Myeloma
@en
P2093
B G M Durie
H Lokhorst
L A Moulopoulos
R L Comenzo
R Niesvizky
P2860
P2888
P304
P3181
P356
10.1038/LEU.2009.89
P407
P577
2009-09-01T00:00:00Z
P5875
P6179
1048483230